Anika Therapeutics | ANIK - Чистый доход





Чистый доход Изменить Дата
Abbott USD 1.08B 699M 2026-03
Agenus USD -10.63M 74.49M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD 30.81M 54.56M 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Insmed USD -328.48M 41.54M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
J&J USD 5.24B 119M 2026-03
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
Ligand Pharmaceuticals USD 117.27M 112.43M 2025-09
MacroGenics USD -14.16M 30.98M 2025-12
Merit Medical Systems USD 41M 2.99M 2026-03
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sanofi EUR 1.61B 2.42B 2026-03
Smith & Nephew USD 293M 79M 2025-12
Stryker USD 745M 104M 2026-03
Surmodics USD -5.32M 6.22M 2025-06
Veracyte USD 41.15M 22.01M 2025-12
Xencor USD -6.65M 626K 2025-12
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03